Jupiter Asset Management Ltd. Purchases 408,905 Shares of Zoetis Inc. $ZTS

Jupiter Asset Management Ltd. lifted its position in shares of Zoetis Inc. (NYSE:ZTS) by 2,954.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 422,743 shares of the company’s stock after acquiring an additional 408,905 shares during the period. Jupiter Asset Management Ltd.’s holdings in Zoetis were worth $65,927,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Brighton Jones LLC increased its holdings in Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after buying an additional 2,978 shares in the last quarter. CWM LLC boosted its holdings in shares of Zoetis by 23.7% during the 1st quarter. CWM LLC now owns 22,367 shares of the company’s stock valued at $3,683,000 after acquiring an additional 4,282 shares during the last quarter. Florida Financial Advisors LLC grew its stake in shares of Zoetis by 57.6% in the first quarter. Florida Financial Advisors LLC now owns 2,464 shares of the company’s stock worth $406,000 after acquiring an additional 901 shares during the period. Signaturefd LLC raised its holdings in shares of Zoetis by 6.9% during the first quarter. Signaturefd LLC now owns 9,613 shares of the company’s stock valued at $1,583,000 after purchasing an additional 618 shares during the last quarter. Finally, Whittier Trust Co. lifted its position in Zoetis by 2.2% during the first quarter. Whittier Trust Co. now owns 12,437 shares of the company’s stock valued at $2,048,000 after purchasing an additional 270 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. UBS Group decreased their target price on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Piper Sandler upped their price objective on Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Monday, August 11th. Leerink Partners cut Zoetis from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Leerink Partnrs downgraded Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Zoetis presently has an average rating of “Moderate Buy” and a consensus target price of $182.50.

Zoetis Stock Performance

NYSE:ZTS opened at $120.09 on Wednesday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The stock has a 50-day simple moving average of $142.82 and a two-hundred day simple moving average of $152.16. The firm has a market capitalization of $52.92 billion, a PE ratio of 20.67, a P/E/G ratio of 2.31 and a beta of 0.90. Zoetis Inc. has a 52-week low of $117.26 and a 52-week high of $181.85.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.7%. Zoetis’s dividend payout ratio is 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.